Calumet’s $317M Loss Masks $1.03B Revenue

Forward-Looking Analysis

No forward-looking earnings data, analyst predictions, or specific revenue/net profit/EPS estimates were provided in the source material for the 2026Q2 report. Consequently, no projected financial metrics or bank recommendations can be synthesized from the provided content. Strict adherence to the requirement that all claims must be sourced from provided news results in an absence of forward-looking earnings expectations, analyst upgrades, downgrades, or price targets in this section. Investors should note that without specific analyst consensus data or management guidance included in the input, no factual earnings preview regarding 2026Q2 performance projections can be constructed.

Historical Performance Review

Calumet’s 2026Q1 results showed significant challenges, with revenue reaching $1.03 billion. However, the company reported a substantial net loss of $317.00 million, resulting in an EPS of $-3.64. Gross profit also turned negative, standing at $-87.50 million. These figures indicate a difficult quarter characterized by shrinking margins and profitability pressures, contrasting sharply with the top-line revenue performance.

Additional News

No recent non-earnings news regarding company movements, new products, M&A activities, or CEO announcements was provided in the source material. The input data contained only historical financial metrics for Q1 2026 and no contemporary corporate developments. Therefore, no summary of recent operational or strategic news can be extracted. Strict adherence to the requirement that all claims must be sourced from provided content results in an absence of reported corporate activities, leadership changes, or market expansions in this section.

Summary & Outlook

Calumet’s financial health appears weakened following a 2026Q1 net loss of $317 million and negative gross profit. While revenue held at $1.03 billion, the inability to maintain profitability signals significant operational risks. The negative EPS of $-3.64 highlights substantial margin compression. Without positive catalysts or new growth drivers identified in the available data, the outlook remains cautious. The transition from potential growth to loss-making operations suggests a bearish stance on near-term prospects, emphasizing the need for improved margin management to restore investor confidence and stabilize financial performance in upcoming quarters.